ADVAIR HFA 230-21 MCG INHALER

fluticasone propionate and salmeterol xinafoate
$35.0248per GM

Strength

230; 21 ug/1; ug/1

NDC

00173071720

Classification

Brand

Dosage Form

AEROSOL, METERED

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021254

On Market Since

3/6/2009

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.2%

3Y

-18.0%

5Y

-18.0%

All

+21.9%